Arif Bilal 4
4 · KalVista Pharmaceuticals, Inc. · Filed Oct 8, 2025
Insider Transaction Report
Form 4
Arif Bilal
Chief Operations Officer
Transactions
- Award
Stock Option (right to buy)
2025-10-08+100,000→ 100,000 totalExercise: $11.49Exp: 2035-10-07→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests over a 4-year period: 25% vests on October 8, 2026, after which 1/48th of the total shares vest monthly, subject to reporting person's continued service through each vesting date.